Loading…
Two-Dimensional "Nanotanks" Release "Gas Bombs" through Photodynamic Cascades to Promote Diabetic Wound Healing
The emergence of multidrug-resistant (MDR) bacterial infections, particularly in diabetic wounds, represents a major challenge in clinical care due to their high mortality rate. Despite the continued use of antibiotics as the primary clinical treatment for diabetic wounds, there is an urgent need to...
Saved in:
Published in: | Biomaterials research 2024, 28(00), , pp.1392-1411 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | The emergence of multidrug-resistant (MDR) bacterial infections, particularly in diabetic wounds, represents a major challenge in clinical care due to their high mortality rate. Despite the continued use of antibiotics as the primary clinical treatment for diabetic wounds, there is an urgent need to develop antibiotic-free therapeutic strategies to combat MDR bacteria, given the limitations and resistance of antibiotics. In this study, a "nanotank", MXene@MOF@CORM-401 (MMC), was designed to target bacteria. The basis of this approach is the combination of 2-dimensional transition metal carbides/carbon nitrides (MXene), metal-organic frameworks (MOFs), and carbon monoxide-releasing molecules (CORMs). MMCs exhibit photothermal and photodynamic properties upon irradiation with near-infrared laser. The photodynamic effect generates a substantial quantity of reactive oxygen species, which subsequently triggers the release of carbon monoxide in a "gas bombs"-like manner. In vitro and in vivo experiments have demonstrated that MMC is not only biocompatible but also exhibits robust antimicrobial properties and accelerates diabetic wound healing. Consequently, this innovative 2-dimensional "nanotank" represents a promising alternative to conventional antibiotic therapies for the treatment of MDR bacterial infections in the future. |
---|---|
ISSN: | 1226-4601 2055-7124 2055-7124 |
DOI: | 10.34133/bmr.0100 |